Examples of using May develop in English and their translations into Finnish
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
Toxic state may develop.
Patients may develop antibodies to AVONEX.
Additionally photophobia may develop.
And then all may develop new wrinkles.
Serum neutralising antibodies against interferon beta-1a may develop.
People also translate
Hypothyroidism may develop during treatment.
During Dynepo therapy, absolute or functional iron deficiency may develop.
Patients may develop antibodies to Plegridy.
At the same time the patient may develop anorexia.
Your teeth may develop a sensitivity to whitening products.
People who handle Halocur repeatedly may develop skin allergies.
Bronchospasm may develop particularly in patients with asthma.
The Proposal foresees that the Commission may develop guidance on sampling.
You may develop new melanoma lesions while taking Zelboraf.
In addition, hypokalaemia may develop as a consequence of diarrhoea.
Severe granulocytopenia, thrombocytopenia, anaemia orany combination thereof may develop.
Some patients may develop antibodies to INCRELEX.
For instance,'El Corte Inglés' has introduced this model in Spain and may develop it further.
Some patients may develop antibodies to rhGH.
Your body may develop antibodies after you received Botulinum toxin type A preparations.
In the first days the patient may develop such severe complications.
A few users may develop a fishy smell due to CDP choline powder degradation on the intestines.
Patients with renal insufficiency may develop hypocalcaemia or hypercalcaemia.
Some patients may develop antibodies to this medicinal product.
As with all protein based medicines,some patients may develop antibodies to the protein.
An expectant mother may develop oligohydramnion- deficiency of amniotic fluid.
Individuals with haemophilia B may develop antibodies(inhibitors) against factor IX.
Above this, one may develop an excessively high androgen level and encounter some problems.
Against erythropoietin these antibodies may develop during treatment and can reduce its effectiveness.
The Commission may develop guidelines providing further guidance on the action plans.